| | | | | The fight over who is responsible for the opioid epidemic that has ravaged the United States heads to court on Monday in Ohio as local governments seek billions of dollars from companies that manufactured and distributed the highly-addictive painkillers. | | |
| | | On Monday, two Ohio counties will face off in a U.S. courtroom with five companies they accuse of fueling the nationwide opioid epidemic. The counties are seeking billions of dollars to cover the cost of addiction treatment programs, healthcare and other services. | | |
| | | Opioid deaths in the United States have soared over the last two decades, driving a wave of litigation against drugmakers and distributors. | | |
| | | The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug. | | |
| | | GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market. | | |
| | | Roche's Tecentriq mixed with Avastin helped liver cancer patients live longer, a boost to the Swiss drugmaker's strategy of expanding its late-to-the-game immunotherapy into niche areas not yet dominated by rivals. | | |
| | | AstraZeneca's diabetes drug Farxiga has been approved for use in the United States as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks, the British drugmaker said on Monday. | | |
| | | Turkish President Tayyip Erdogan said on Sunday he will never allow electronic cigarette companies to produce their products in Turkey, urging Turks to drink tea instead. | | |
| | | A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on a settlement on Friday that had been expected to be valued at around $50 billion. | | |
| | | The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said. | | |
| | | Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. | | |
|
| |
